Cara Therapeutics | CARA - Debt

Stock Price
4.18
Daily Change
-0.03 -0.71%
Monthly
41.22%
Yearly
-83.68%
Q2 Forecast
3.07

Cara Therapeutics reported $0 in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Acadia Pharmaceuticals USD 52.19M 2.62M Dec/2025
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Assertio Holdings USD 38.87M 615K Sep/2023
Cara Therapeutics USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Chugai Pharma JPY 14.11B 1.93B Dec/2022
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
CSL USD 11.96B 219M Dec/2024
Grifols EUR 9.23B 626.05M Dec/2024
Halozyme Therapeutics USD 1.51B 1.66M Sep/2025
J&J USD 47.93B 2.14B Dec/2025
Neurocrine Biosciences USD 415.3M 13.1M Dec/2025
Pacira USD 367.66M 4.53M Mar/2026
Pfizer USD 63.96B 3.11B Dec/2025
RedHill Biopharma USD 214K 142K Jun/2025
Supernus Pharmaceuticals USD 40.98M 1.23M Dec/2025
Vanda Pharmaceuticals USD 4.96M 4.96M Dec/2024